Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Antagonizing the Ghrelin Receptor in Individuals With Obesity on Treatment With Semaglutide

NCT07171723 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT07171723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07171723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Antagonizing the Ghrelin Receptor in Individuals With Obesity on Treatment With Semaglutide
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2025
Completion date
August 12, 2026
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight